PARP11: A Novel Regulator in Cellular Homeostasis and Disease Pathogenesis

PARP11: A Novel Regulator in Cellular Homeostasis and Disease Pathogenesis

PARP11: A Novel Regulator in Cellular Homeostasis and Disease Pathogenesis

Official Exclusive Article from ANT BIO PTE. LTD.

1. Concept

Poly(ADP-ribose) polymerase 11 (PARP11) is a novel and under‑investigated member of the PARP family, which mediates mono‑ or poly‑ADP‑ribosylation of target proteins to regulate signaling transduction, gene transcription, cell cycle progression, and stress responses. Unlike classic PARP1 and PARP2, PARP11 localizes in the nucleus, cytoplasm, and cell membrane, and exerts biological functions beyond DNA repair, making it a newly emerging hub in cellular regulation.

2. Research Frontiers

Recent studies have revealed that PARP11:

  • Acts as a critical transcriptional regulator by modifying RNA polymerase II and transcription factors such as NF‑κB;
  • Controls cell cycle progression via regulating p53, Cyclin D, and CDK complexes;
  • Participates in cellular stress responses including oxidative stress, heat stress, and DNA damage;
  • Is abnormally expressed in cancer, neurodegenerative diseases, and immune disorders, and may serve as a potential diagnostic marker and therapeutic target.

3. Research Significance

PARP11 represents a new frontier in PARP family research. Clarifying its molecular mechanisms will deepen the understanding of cell fate determination, stress adaptation, and disease development. Moreover, PARP11‑targeted intervention provides a novel strategy for cancer therapy, neuroprotection, and immune‑related disease treatment.

4. Related Mechanisms and Research Applications

4.1 Molecular Mechanisms

PARP11 catalyzes the transfer of ADP‑ribose units from NAD+ to substrate proteins, thereby modulating protein activity, stability, protein–protein interactions, and subcellular localization. It regulates:

  • Transcription: activation or inhibition of RNA polymerase II and transcription factors;
  • Cell cycle: stability and function of cell cycle regulators;
  • Stress response: activation of stress‑related signaling pathways;
  • Disease progression: promotion or suppression of malignant phenotypes.

4.2 Research Methods and Product Applications

Research on PARP11 requires high‑quality reagents for protein detection, functional analysis, and pathway validation. ANT BIO PTE. LTD. provides a complete set of reagents to support PARP11 research:

  • Antibody detection: PARP11‑specific antibodies for WB, IHC, IF, IP;
  • Functional analysis: NAD+ assay kits, ADP‑ribosylation detection kits;
  • Pathway verification: transcription factor and cell cycle‑related reagents.

5. Brand Mission

ANT BIO PTE. LTD. is a professional supplier of life science reagents, dedicated to providing high‑quality antibodies, recombinant proteins, kits, and universal reagents to accelerate scientific discovery. We own three specialized sub‑brands:

  • Absin: universal reagents and detection kits;
  • Starter: high‑quality antibodies;
  • UA: recombinant proteins.

We are committed to empowering global researchers with reliable tools to unlock the mysteries of life science and promote medical progress.

6. Related Product List

表格

Sub‑Brand

Product Category

Typical Products for PARP11 Research

Absin

Universal reagents & kits

NAD+ assay kit; ADP‑ribosylation detection kit; WB buffer system

Starter

Antibodies

PARP11 antibody; p53 antibody; NF‑κB antibody; Cyclin D antibody

UA

Recombinant proteins

PARP11 recombinant protein; related regulatory proteins

 

8. Brand Promotion

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.